FDA Approves First Alzheimer's Blood Test for Ages 40 and Up

Hemoglobin A1c, commonly known as HbA1c or glycated hemoglobin, is a crucial blood test used to measure average blood sugar levels over the past two to three months. This test provides valuable information about how well diabetes is being managed or can help diagnose diabetes and prediabetes. Unlike regular blood glucose tests that capture a single moment in time, HbA1c reflects long-term glucose control by measuring the percentage of hemoglobin proteins in red blood cells that have glucose attached to them.

When glucose enters the bloodstream, it binds to hemoglobin in red blood cells through a process called glycation. Since red blood cells live for approximately three months, the HbA1c test effectively shows the average blood sugar concentration during that period. The higher the glucose levels in the blood, the more hemoglobin becomes glycated. This makes HbA1c an excellent indicator of overall glycemic control and helps healthcare providers assess the effectiveness of diabetes treatment plans.

For diagnostic purposes, HbA1c levels are interpreted as follows: a normal result is below 5.7 percent, prediabetes is indicated by levels between 5.7 and 6.4 percent, and diabetes is diagnosed when HbA1c is 6.5 percent or higher on two separate tests. For people already diagnosed with diabetes, the target HbA1c level is typically below 7 percent, though individual goals may vary based on age, overall health, and other factors. Regular monitoring helps prevent complications associated with poorly controlled diabetes, such as kidney disease, nerve damage, and cardiovascular problems.

The HbA1c test offers several advantages over traditional glucose monitoring. It requires no fasting or special preparation, can be performed at any time of day, and is not affected by short-term fluctuations in blood sugar caused by stress, illness, or recent meals. However, certain conditions can affect test accuracy, including anemia, recent blood transfusions, certain hemoglobin variants, kidney or liver disease, and pregnancy. People with these conditions may need alternative testing methods or more frequent monitoring to ensure accurate assessment of their blood sugar control.